Aldeyra Therapeutics, Inc.

Direct answer

Aldeyra Therapeutics, Inc. is publicly traded on NASDAQ under the ticker ALDX.

Aldeyra Therapeutics, Inc. is a biotechnology company focused on the discovery and commercialization of therapeutic agents for ocular and systemic immune-mediated disorders. The firm's primary investigational compound is reproxalap, a reactive aldehyde species (RASP) modulator, currently in Phase III clinical trials for addressing dry eye disease and allergic conjunctivitis. Additionally, Aldeyra is advancing...

Can you invest in Aldeyra Therapeutics, Inc.?

Yes. Aldeyra Therapeutics, Inc. trades publicly on NASDAQ as ALDX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Aldeyra Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.